Danazol in the treatment of endometrial hyperplasia.

R Grio; R Piacentino; Marchino Gl; A Bocci; R Navone

Danazol in the treatment of endometrial hyperplasia.

R Grio, R Piacentino, Marchino Gl, A Bocci, R Navone

In: Panminerva medica · 1993 · vol. 35(4) , pp. 231–3 · PMID:8202337 · W2413751283

article OA: closed CC0 ⤵ 2 in-corpus citations

View on OpenAlex View on PubMed

Abstract

The paper reports the results of a study performed in 62 menorrhagic women with endometrial hyperplasia treated with Danazol. The efficacy and tolerability of the above drug was found to be satisfactory.

My notes (saved in your browser only)

Citation neighborhood (sparse)

Too few in-corpus citations on either side for a chart; here are the lists.

Cited by (2)

Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003
Therapeutic Options for Management of Endometrial Hyperplasia: An Update 2015

Cited by (2)

Therapeutic Options for Management of Endometrial Hyperplasia: An Update 2015
Phase II trial of danazol in advanced, recurrent, or persistent endometrial cancer: a Gynecologic Oncology Group study 2003

SciLite annotations

chemicals 2

danazol danazol

organisms 1

noordeloos 2009062

Source provenance

openalex: last seen: 2026-06-10T17:14:06.276822+00:00
scilite: last seen: 2026-05-18T04:25:29.313245+00:00

License: CC0 · commercial use OK